WBA - Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement | Benzinga
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.
This impending case marks a significant showdown over abortion rights, emerging shortly after the court's conservative majority decided to overturn Roe v. Wade less than two years ago.
The case revolves around the FDA's endorsement of mifepristone. The potential outcome could lead the court, which previously ruled 6-3, to overturn Roe and decide on this matter sometime in the forthcoming year.